463 related articles for article (PubMed ID: 19501358)
1. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
Aucella F; Maas R; Vigilante M; Tripepi G; Schwedhelm E; Margaglione M; Gesualdo L; Boeger R; Zoccali C
Atherosclerosis; 2009 Dec; 207(2):541-5. PubMed ID: 19501358
[TBL] [Abstract][Full Text] [Related]
2. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
Busch M; Fleck C; Wolf G; Stein G
Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
[TBL] [Abstract][Full Text] [Related]
3. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
[TBL] [Abstract][Full Text] [Related]
4. Dimethylarginine levels and nutritional status in hemodialysis patients.
Cupisti A; Saba A; D'Alessandro C; Meola M; Panicucci E; Panichi V; Raffaelli A; Barsotti G
J Nephrol; 2009; 22(5):623-9. PubMed ID: 19809995
[TBL] [Abstract][Full Text] [Related]
5. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
Shafi T; Hostetter TH; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Powe NR
Am J Kidney Dis; 2017 Jul; 70(1):48-58. PubMed ID: 28089476
[TBL] [Abstract][Full Text] [Related]
6. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach.
Ravani P; Tripepi G; Malberti F; Testa S; Mallamaci F; Zoccali C
J Am Soc Nephrol; 2005 Aug; 16(8):2449-55. PubMed ID: 15944335
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
[TBL] [Abstract][Full Text] [Related]
9. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
[TBL] [Abstract][Full Text] [Related]
10. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
Schulze F; Carter AM; Schwedhelm E; Ajjan R; Maas R; von Holten RA; Atzler D; Grant PJ; Böger RH
Atherosclerosis; 2010 Feb; 208(2):518-23. PubMed ID: 19700158
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.
Tripepi G; Mattace Raso F; Sijbrands E; Seck MS; Maas R; Boger R; Witteman J; Rapisarda F; Malatino L; Mallamaci F; Zoccali C
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1714-21. PubMed ID: 21642364
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.
Siegerink B; Maas R; Vossen CY; Schwedhelm E; Koenig W; Böger R; Rothenbacher D; Brenner H; Breitling LP
Clin Res Cardiol; 2013 Mar; 102(3):193-202. PubMed ID: 23073705
[TBL] [Abstract][Full Text] [Related]
13. Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.
Lüneburg N; von Holten RA; Töpper RF; Schwedhelm E; Maas R; Böger RH
Clin Sci (Lond); 2012 Feb; 122(3):105-11. PubMed ID: 21777201
[TBL] [Abstract][Full Text] [Related]
14. Association of homoarginine and methylarginines with liver dysfunction and mortality in chronic liver disease.
Pilz S; Putz-Bankuti C; Meinitzer A; März W; Kienreich K; Stojakovic T; Pieber TR; Stauber RE
Amino Acids; 2015 Sep; 47(9):1817-26. PubMed ID: 25952253
[TBL] [Abstract][Full Text] [Related]
15. Symmetric dimethylarginine is an independent predictor of intradialytic hypotension.
Mangoni AA; Hewitson CL; Woodman RJ; Whiting MJ; McAteer-Carr B; Barbara JA
Am J Hypertens; 2008 Aug; 21(8):955-9. PubMed ID: 18551101
[TBL] [Abstract][Full Text] [Related]
16. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
Hov GG; Aasarød KI; Sagen E; Åsberg A
Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
[TBL] [Abstract][Full Text] [Related]
17. Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study.
Gore MO; Lüneburg N; Schwedhelm E; Ayers CR; Anderssohn M; Khera A; Atzler D; de Lemos JA; Grant PJ; McGuire DK; Böger RH
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2682-8. PubMed ID: 24008162
[TBL] [Abstract][Full Text] [Related]
18. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.
Zoccali C; Bode-Böger S; Mallamaci F; Benedetto F; Tripepi G; Malatino L; Cataliotti A; Bellanuova I; Fermo I; Frölich J; Böger R
Lancet; 2001 Dec 22-29; 358(9299):2113-7. PubMed ID: 11784625
[TBL] [Abstract][Full Text] [Related]
20. High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis.
Mortensen KM; Itenov TS; Haase N; Müller RB; Ostrowski SR; Johansson PI; Olsen NV; Perner A; Søe-Jensen P; Bestle MH
Shock; 2016 Oct; 46(4):365-72. PubMed ID: 27206279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
